MRUS – Merus N.V

Float Short %

2.19

Margin Of Safety %

Put/Call OI Ratio

1.63

EPS Next Q Diff

-0.06

EPS Last/This Y

-2.33

EPS This/Next Y

1.06

Price

96.14

Target Price

Analyst Recom

2.76

Performance Q

43.09

Relative Volume

0.29

Beta

1.08

Ticker: MRUS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	MRUS	95.44	1.28	31.93	54966
2025-11-11	MRUS	95.5	1.28	0.76	54886
2025-11-12	MRUS	96.04	1.29	0.50	54708
2025-11-13	MRUS	96.06	1.29	0.28	54988
2025-11-14	MRUS	95.98	1.31	6.80	54560
2025-11-17	MRUS	95.9	1.31	4.26	54697
2025-11-18	MRUS	95.79	1.32	5.63	54743
2025-11-19	MRUS	96.05	1.32	0.87	54817
2025-11-20	MRUS	95.99	1.32	1.22	55185
2025-11-21	MRUS	95.76	1.32	0.78	56084
2025-11-24	MRUS	95.94	1.46	1.07	53024
2025-11-25	MRUS	96.04	1.44	1.29	53174
2025-11-26	MRUS	96.08	1.45	2.14	54350
2025-12-01	MRUS	95.97	1.46	1.95	57088
2025-12-02	MRUS	96	1.46	3.65	58118
2025-12-03	MRUS	96.12	1.69	2.23	55845
2025-12-04	MRUS	96.22	1.68	0.77	56882
2025-12-05	MRUS	96.12	1.63	0.97	57717
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	MRUS	95.42	-84.2	1.1	-5.30
2025-11-11	MRUS	95.48	-94.2	1.8	-5.42
2025-11-12	MRUS	96.03	-94.2	-0.4	-5.42
2025-11-13	MRUS	96.07	-94.2	1.7	-5.42
2025-11-14	MRUS	95.98	-94.2	2.4	-5.42
2025-11-17	MRUS	95.90	-94.2	2.4	-5.42
2025-11-18	MRUS	95.79	-114.9	2.3	-5.62
2025-11-19	MRUS	96.04	-114.9	0.9	-5.62
2025-11-20	MRUS	95.98	-114.9	2.2	-5.62
2025-11-21	MRUS	95.75	-114.9	2.9	-5.68
2025-11-24	MRUS	95.92	-114.9	1.2	-5.68
2025-11-25	MRUS	96.02	-116.3	1.6	-5.68
2025-11-26	MRUS	96.08	-116.3	1.7	-5.68
2025-12-01	MRUS	95.97	-116.3	2.7	-5.68
2025-12-02	MRUS	95.99	-116.3	1.7	-5.68
2025-12-03	MRUS	96.12	-116.3	1.4	-5.68
2025-12-04	MRUS	96.23	-116.3	1.5	-5.68
2025-12-05	MRUS	96.14	-116.3	2.2	-5.68
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	MRUS	-1.07	-4.02	3.25
2025-11-11	MRUS	-1.07	-4.02	3.25
2025-11-12	MRUS	-1.07	-4.02	2.50
2025-11-13	MRUS	-1.07	-4.02	2.50
2025-11-14	MRUS	-1.07	-4.02	2.50
2025-11-17	MRUS	-1.07	-3.36	2.50
2025-11-18	MRUS	-1.07	-3.36	2.47
2025-11-19	MRUS	-1.20	-3.36	2.47
2025-11-20	MRUS	-1.20	-3.36	2.45
2025-11-21	MRUS	-1.34	-3.36	2.45
2025-11-24	MRUS	-1.34	-7.43	2.45
2025-11-25	MRUS	-1.34	-7.43	2.45
2025-11-26	MRUS	-1.34	-7.43	2.19
2025-12-01	MRUS	-1.47	-7.59	2.19
2025-12-02	MRUS	-1.47	-7.59	2.19
2025-12-03	MRUS	-1.47	-7.59	2.19
2025-12-04	MRUS	-1.47	-7.59	2.19
2025-12-05	MRUS	-1.47	-7.59	2.19
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-1.23

Avg. EPS Est. Current Quarter

-1.06

Avg. EPS Est. Next Quarter

-1.29

Insider Transactions

-1.47

Institutional Transactions

-7.59

Beta

1.08

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

0.2

Max Drawdown 5-Year %

-60.4

Target Price

P/E

Forward P/E

PEG

P/S

128.81

P/B

9.41

P/Free Cash Flow

EPS

-5.33

Average EPS Est. Cur. Y

-5.68

EPS Next Y. (Est.)

-4.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-673.31

Relative Volume

0.29

Return on Equity vs Sector %

-76.1

Return on Equity vs Industry %

-61.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.08

EBIT Estimation

2.2

Merus N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 260

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes BIZENGRI for the treatment of patients with pancreatic adenocarcinoma or non-small cell lung cancer (NSCLC) and non Neuregulin 1. The company is also developing MCLA-158 for the treatment of solid tumors; MCLA-129 for the treatment of patients with lungs and other solid tumors; ONO-4685 to treat relapsed/refractory T cell lymphoma; and INCA33890 for advanced solid tumors. In addition, it has collaboration agreement with Eli Lilly and Company, Ono Pharmaceutical Co., Ltd., and Betta Pharmaceuticals Co. Ltd. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

stock quote shares MRUS – Merus N.V Stock Price stock today

news today MRUS – Merus N.V stock forecast ,stock prediction 2023 2024 2025

marketwatch MRUS – Merus N.V yahoo finance google finance

stock history MRUS – Merus N.V invest stock market

stock prices MRUS premarket after hours

ticker MRUS fair value insiders trading

QGEN – Qiagen N.V.

Float Short %

2.86

Margin Of Safety %

Put/Call OI Ratio

0.78

EPS Next Q Diff

-0.03

EPS Last/This Y

EPS This/Next Y

0.15

Price

47.01

Target Price

51.43

Analyst Recom

2.21

Performance Q

-1.2

Relative Volume

1.61

Beta

0.66

Ticker: QGEN

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	QGEN	43.16	0.35	999.99	10158
2025-11-11	QGEN	44.22	0.35	999.99	10158
2025-11-12	QGEN	44.53	0.35	999.99	10158
2025-11-13	QGEN	44.65	0.35	999.99	10161
2025-11-14	QGEN	44.31	0.35	0.13	10161
2025-11-17	QGEN	44.13	0.35	0.24	10204
2025-11-18	QGEN	44.35	0.29	0.61	20311
2025-11-19	QGEN	44.43	0.33	0.58	22770
2025-11-20	QGEN	45.68	0.36	0.05	24132
2025-11-21	QGEN	46.84	0.37	2.17	23723
2025-11-24	QGEN	47.22	0.67	0.99	17229
2025-11-25	QGEN	48.56	0.74	0.00	17469
2025-11-26	QGEN	48.1	0.74	0.12	17442
2025-12-01	QGEN	47.34	0.74	1.18	17502
2025-12-02	QGEN	46.94	0.79	0.25	17864
2025-12-03	QGEN	46.82	0.80	1.22	17790
2025-12-04	QGEN	47.06	0.82	0.25	17922
2025-12-05	QGEN	47.01	0.78	0.15	19398
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	QGEN	43.17	-1.0	92.6	2.37
2025-11-11	QGEN	44.22	-2.2	113.0	2.36
2025-11-12	QGEN	44.53	-2.2	102.3	2.36
2025-11-13	QGEN	44.65	-2.2	99.6	2.36
2025-11-14	QGEN	44.30	-2.2	93.3	2.36
2025-11-17	QGEN	44.13	-2.2	95.5	2.39
2025-11-18	QGEN	44.36	-2.2	101.3	2.39
2025-11-19	QGEN	44.43	-2.2	99.2	2.39
2025-11-20	QGEN	45.68	-2.3	115.3	2.39
2025-11-21	QGEN	46.83	-2.3	113.7	2.39
2025-11-24	QGEN	47.22	-2.3	103.0	2.39
2025-11-25	QGEN	48.56	-2.3	115.5	2.39
2025-11-26	QGEN	48.10	-2.3	92.3	2.39
2025-12-01	QGEN	47.33	-2.3	92.6	2.39
2025-12-02	QGEN	46.94	-2.3	92.9	2.39
2025-12-03	QGEN	46.82	-2.3	96.5	2.39
2025-12-04	QGEN	47.05	-2.3	101.1	2.39
2025-12-05	QGEN	47.01	-2.3	97.2	2.39
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	QGEN	0.00	0.55	2.78
2025-11-11	QGEN	0.00	0.55	2.78
2025-11-12	QGEN	0.00	0.55	2.83
2025-11-13	QGEN	0.00	0.55	2.83
2025-11-14	QGEN	0.00	0.55	2.83
2025-11-17	QGEN	0.00	-1.33	2.83
2025-11-18	QGEN	0.00	-1.33	2.83
2025-11-19	QGEN	0.00	-1.33	2.83
2025-11-20	QGEN	0.00	-1.33	2.83
2025-11-21	QGEN	0.00	-1.33	2.83
2025-11-24	QGEN	0.00	2.62	2.83
2025-11-25	QGEN	0.00	2.62	2.83
2025-11-26	QGEN	0.00	2.62	2.86
2025-12-01	QGEN	0.00	4.14	2.86
2025-12-02	QGEN	0.00	4.14	2.86
2025-12-03	QGEN	0.00	4.14	2.86
2025-12-04	QGEN	0.00	4.14	2.86
2025-12-05	QGEN	0.00	4.14	2.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.61

Avg. EPS Est. Current Quarter

0.6

Avg. EPS Est. Next Quarter

0.58

Insider Transactions

Institutional Transactions

4.14

Beta

0.66

Average Sales Estimate Current Quarter

528

Average Sales Estimate Next Quarter

510

Fair Value

51.01

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

24.9

Max Drawdown 5-Year %

-37.4

Target Price

51.43

P/E

25.36

Forward P/E

18.68

PEG

3.54

P/S

4.92

P/B

2.79

P/Free Cash Flow

21.29

EPS

1.85

Average EPS Est. Cur. Y

2.39

EPS Next Y. (Est.)

2.54

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.58

Relative Volume

1.61

Return on Equity vs Sector %

-15.8

Return on Equity vs Industry %

0.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

97.2

Qiagen N.V.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 5700

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

stock quote shares QGEN – Qiagen N.V. Stock Price stock today

news today QGEN – Qiagen N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch QGEN – Qiagen N.V. yahoo finance google finance

stock history QGEN – Qiagen N.V. invest stock market

stock prices QGEN premarket after hours

ticker QGEN fair value insiders trading

ARGX – argenx SE

Float Short %

3.01

Margin Of Safety %

-22

Put/Call OI Ratio

0.44

EPS Next Q Diff

0.74

EPS Last/This Y

1.09

EPS This/Next Y

10.4

Price

901.17

Target Price

961.88

Analyst Recom

1.32

Performance Q

17.34

Relative Volume

0.64

Beta

0.37

Ticker: ARGX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	ARGX	870.11	0.64	0.16	12979
2025-11-11	ARGX	891.51	0.63	0.20	13195
2025-11-12	ARGX	889.59	0.62	0.17	13407
2025-11-13	ARGX	892.33	0.62	1.03	13525
2025-11-14	ARGX	908.1	0.62	0.47	13705
2025-11-17	ARGX	928.69	0.62	0.41	13759
2025-11-18	ARGX	916.77	0.62	0.36	13854
2025-11-19	ARGX	913.43	0.62	1.16	13945
2025-11-20	ARGX	918.65	0.62	0.22	14126
2025-11-21	ARGX	918.78	0.62	0.26	14159
2025-11-24	ARGX	906.1	0.49	0.07	10685
2025-11-25	ARGX	917.58	0.44	0.13	11601
2025-11-26	ARGX	918.25	0.46	0.45	12020
2025-12-01	ARGX	895.67	0.44	0.58	11801
2025-12-02	ARGX	915.29	0.45	0.61	12026
2025-12-03	ARGX	921.9	0.45	0.10	12209
2025-12-04	ARGX	916.05	0.45	0.07	12293
2025-12-05	ARGX	900.72	0.44	4.30	12381
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	ARGX	869.83	598.4	150.1	15.00
2025-11-11	ARGX	889.64	594.6	175.1	14.98
2025-11-12	ARGX	889.48	594.6	114.4	14.97
2025-11-13	ARGX	892.53	594.6	97.0	14.97
2025-11-14	ARGX	907.86	594.6	116.6	14.97
2025-11-17	ARGX	928.90	594.6	150.8	15.00
2025-11-18	ARGX	918.46	594.6	118.7	15.00
2025-11-19	ARGX	914.59	594.6	127.8	15.00
2025-11-20	ARGX	918.84	594.6	119.7	15.00
2025-11-21	ARGX	918.28	594.6	99.8	15.00
2025-11-24	ARGX	906.50	606.3	104.9	15.01
2025-11-25	ARGX	917.93	606.3	137.1	15.01
2025-11-26	ARGX	917.91	606.3	127.7	15.01
2025-12-01	ARGX	895.36	606.5	113.5	15.01
2025-12-02	ARGX	915.36	606.5	155.5	15.01
2025-12-03	ARGX	921.80	606.5	137.6	15.01
2025-12-04	ARGX	915.91	606.5	110.6	15.01
2025-12-05	ARGX	901.17	606.8	91.2	15.01
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	ARGX	0.00	32.19	3.04
2025-11-11	ARGX	0.00	32.19	3.04
2025-11-12	ARGX	0.00	32.19	2.77
2025-11-13	ARGX	0.00	32.19	2.77
2025-11-14	ARGX	0.00	32.19	2.77
2025-11-17	ARGX	0.00	8.64	2.77
2025-11-18	ARGX	0.00	8.64	2.77
2025-11-19	ARGX	0.00	8.64	2.77
2025-11-20	ARGX	0.00	8.64	2.77
2025-11-21	ARGX	0.00	8.64	2.76
2025-11-24	ARGX	0.00	1.75	2.76
2025-11-25	ARGX	0.00	1.75	2.76
2025-11-26	ARGX	0.00	1.75	3.01
2025-12-01	ARGX	0.00	24.91	3.01
2025-12-02	ARGX	0.00	24.91	3.01
2025-12-03	ARGX	0.00	24.91	3.01
2025-12-04	ARGX	0.00	24.91	3.01
2025-12-05	ARGX	0.00	24.91	3.01
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

5.18

Avg. EPS Est. Current Quarter

5.04

Avg. EPS Est. Next Quarter

5.92

Insider Transactions

Institutional Transactions

24.91

Beta

0.37

Average Sales Estimate Current Quarter

1102

Average Sales Estimate Next Quarter

1181

Fair Value

705.67

Quality Score

100

Growth Score

Sentiment Score

Actual DrawDown %

3.6

Max Drawdown 5-Year %

-38.2

Target Price

961.88

P/E

45.81

Forward P/E

29.85

PEG

1.03

P/S

18.12

P/B

9.04

P/Free Cash Flow

103.43

EPS

19.67

Average EPS Est. Cur. Y

15.01

EPS Next Y. (Est.)

25.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

41.87

Relative Volume

0.64

Return on Equity vs Sector %

-14.3

Return on Equity vs Industry %

0.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

91.2

argenx SE

Sector: Healthcare

Industry: Biotechnology

Employees: 1599

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.

stock quote shares ARGX – argenx SE Stock Price stock today

news today ARGX – argenx SE stock forecast ,stock prediction 2023 2024 2025

marketwatch ARGX – argenx SE yahoo finance google finance

stock history ARGX – argenx SE invest stock market

stock prices ARGX premarket after hours

ticker ARGX fair value insiders trading

STLA – Stellantis N.V.

Float Short %

2.47

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

EPS Last/This Y

-1.32

EPS This/Next Y

1.14

Price

12.05

Target Price

11.14

Analyst Recom

2.59

Performance Q

34.49

Relative Volume

0.84

Beta

1.41

Ticker: STLA

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	STLA	10.35	0.65	0.71	430690
2025-11-11	STLA	10.77	0.65	0.25	431481
2025-11-12	STLA	10.72	0.65	0.52	432472
2025-11-13	STLA	10.62	0.65	0.80	432483
2025-11-14	STLA	10.39	0.64	1.31	431163
2025-11-17	STLA	9.98	0.64	0.40	423934
2025-11-18	STLA	9.73	0.63	0.86	427924
2025-11-19	STLA	9.69	0.63	0.69	427779
2025-11-20	STLA	9.23	0.62	1.03	426751
2025-11-21	STLA	9.87	0.61	0.54	425046
2025-11-24	STLA	10.14	0.58	0.43	405533
2025-11-25	STLA	10.54	0.57	0.30	408376
2025-11-26	STLA	10.33	0.57	0.79	409272
2025-12-01	STLA	10.65	0.57	0.97	409586
2025-12-02	STLA	10.96	0.57	0.14	410316
2025-12-03	STLA	11.47	0.57	0.13	412164
2025-12-04	STLA	11.84	0.57	0.28	415631
2025-12-05	STLA	12.06	0.56	0.08	425318
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	STLA	10.36	-	10603.5	0.86
2025-11-11	STLA	10.76	-	10766.2	0.86
2025-11-12	STLA	10.72	-	10480.7	0.86
2025-11-13	STLA	10.62	-	10470.2	0.86
2025-11-14	STLA	10.39	-	10376.8	0.86
2025-11-17	STLA	9.98	-	10315.2	0.86
2025-11-18	STLA	9.73	-	10313.6	0.86
2025-11-19	STLA	9.69	-	10394.0	0.86
2025-11-20	STLA	9.23	-	10420.9	0.86
2025-11-21	STLA	9.86	-	10799.0	0.86
2025-11-24	STLA	10.13	-	10782.6	0.86
2025-11-25	STLA	10.54	-	10813.1	0.86
2025-11-26	STLA	10.32	-	10576.6	0.85
2025-12-01	STLA	10.65	-	10641.0	0.85
2025-12-02	STLA	10.95	-	10747.2	0.85
2025-12-03	STLA	11.46	-	10826.2	0.85
2025-12-04	STLA	11.83	-	11811.7	0.85
2025-12-05	STLA	12.05	-	10754.4	0.85
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	STLA	0.00	-5.48	2.42
2025-11-11	STLA	0.00	-5.48	2.42
2025-11-12	STLA	0.00	-5.48	2.21
2025-11-13	STLA	0.00	-5.48	2.21
2025-11-14	STLA	0.00	-5.48	2.21
2025-11-17	STLA	0.00	-6.37	2.21
2025-11-18	STLA	0.00	-6.37	2.21
2025-11-19	STLA	0.00	-6.37	2.21
2025-11-20	STLA	0.00	-6.37	2.21
2025-11-21	STLA	0.00	-6.37	2.21
2025-11-24	STLA	0.00	-3.19	2.21
2025-11-25	STLA	0.00	-3.19	2.21
2025-11-26	STLA	0.00	-3.19	2.47
2025-12-01	STLA	0.00	-3.47	2.47
2025-12-02	STLA	0.00	-3.47	2.47
2025-12-03	STLA	0.00	-3.47	2.47
2025-12-04	STLA	0.00	-3.47	2.47
2025-12-05	STLA	0.00	-3.47	2.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-3.47

Beta

1.41

Average Sales Estimate Current Quarter

35959

Average Sales Estimate Next Quarter

41394

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

59.2

Max Drawdown 5-Year %

-68.8

Target Price

11.14

P/E

Forward P/E

6.68

PEG

P/S

0.22

P/B

0.41

P/Free Cash Flow

EPS

-0.91

Average EPS Est. Cur. Y

0.85

EPS Next Y. (Est.)

1.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1.64

Relative Volume

0.84

Return on Equity vs Sector %

-21.8

Return on Equity vs Industry %

-11

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

10754.4

Stellantis N.V.

Sector: Consumer Cyclical

Industry: Auto Manufacturers

Employees: 248243

Stellantis N.V. engages in the design, engineering, manufacturing, distribution, and sale of automobiles and light commercial vehicles, engines, transmission systems, metallurgical products, mobility services, and production systems worldwide. It provides luxury and premium vehicles; global sport utility vehicles; American and European brand vehicles, as well as parts and accessories. The company also provides contract services; retail and dealer financing services; and leasing and rental services. It offers its products under the Abarth, Alfa Romeo, Chrysler, Citroën, DS, Dodge, FIAT, Jeep, Maserati, Ram, Opel, Lancia, Vauxhall, Peugeot, and Comau brand names through distributors and dealers. Stellantis N.V. was founded in 1899 and is based in Hoofddorp, the Netherlands.

stock quote shares STLA – Stellantis N.V. Stock Price stock today

news today STLA – Stellantis N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch STLA – Stellantis N.V. yahoo finance google finance

stock history STLA – Stellantis N.V. invest stock market

stock prices STLA premarket after hours

ticker STLA fair value insiders trading

PHG – Koninklijke Philips N.V.

Float Short %

0.18

Margin Of Safety %

Put/Call OI Ratio

1.37

EPS Next Q Diff

EPS Last/This Y

-0.18

EPS This/Next Y

0.38

Price

27.05

Target Price

30.8

Analyst Recom

2.22

Performance Q

-2.91

Relative Volume

0.94

Beta

0.78

Ticker: PHG

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	PHG	28.24	1.41	0.85	10540
2025-11-11	PHG	29.34	1.41	0.25	10536
2025-11-12	PHG	29.38	1.40	47.14	10571
2025-11-13	PHG	28.92	1.56	3.65	11246
2025-11-14	PHG	28.65	1.57	0.05	11307
2025-11-17	PHG	28	1.48	0.13	11566
2025-11-18	PHG	27.49	1.39	0.56	11891
2025-11-19	PHG	27.04	1.38	0.89	11907
2025-11-20	PHG	26.71	1.37	4.75	11899
2025-11-21	PHG	27.25	1.34	0.12	11778
2025-11-24	PHG	27.38	1.59	0.02	9439
2025-11-25	PHG	27.85	1.52	0.16	9604
2025-11-26	PHG	28.07	1.51	0.71	9663
2025-12-01	PHG	28.34	1.50	0.79	9727
2025-12-02	PHG	28.22	1.49	0.71	9755
2025-12-03	PHG	28.04	1.48	5.64	9759
2025-12-04	PHG	26.67	1.49	0.25	9775
2025-12-05	PHG	27.06	1.37	1.00	10159
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	PHG	28.25	-9.4	776.6	1.36
2025-11-11	PHG	29.33	-9.4	838.7	1.44
2025-11-12	PHG	29.38	-9.4	791.2	1.44
2025-11-13	PHG	28.92	-9.4	741.8	1.44
2025-11-14	PHG	28.67	-9.4	727.9	1.44
2025-11-17	PHG	28.00	-9.4	730.3	1.44
2025-11-18	PHG	27.50	-9.4	730.3	1.44
2025-11-19	PHG	27.06	-9.4	732.7	1.44
2025-11-20	PHG	26.70	-9.4	732.1	1.44
2025-11-21	PHG	27.25	-9.4	784.9	1.44
2025-11-24	PHG	27.38	-9.4	784.1	1.44
2025-11-25	PHG	27.85	-9.4	791.5	1.44
2025-11-26	PHG	28.07	-9.4	788.4	1.44
2025-12-01	PHG	28.32	-9.4	787.0	1.44
2025-12-02	PHG	28.23	-9.4	767.9	1.44
2025-12-03	PHG	28.04	-9.4	762.1	1.44
2025-12-04	PHG	26.66	-9.4	687.3	1.44
2025-12-05	PHG	27.05	-9.4	710.2	1.44
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	PHG	0	-3.04	0.23
2025-11-11	PHG	0	-3.04	0.23
2025-11-12	PHG	0	-3.04	0.21
2025-11-13	PHG	0	-3.04	0.21
2025-11-14	PHG	0	-3.04	0.21
2025-11-17	PHG	0	-2.28	0.21
2025-11-18	PHG	0	-2.28	0.21
2025-11-19	PHG	0	-2.28	0.21
2025-11-20	PHG	0	-2.28	0.21
2025-11-21	PHG	0	-2.28	0.21
2025-11-24	PHG	0	0.44	0.21
2025-11-25	PHG	0	0.44	0.21
2025-11-26	PHG	0	0.44	0.18
2025-12-01	PHG	0	1.12	0.18
2025-12-02	PHG	0	1.12	0.18
2025-12-03	PHG	0	1.12	0.18
2025-12-04	PHG	0	1.12	0.18
2025-12-05	PHG	0	1.12	0.18
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.37

Avg. EPS Est. Current Quarter

0.48

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

1.12

Beta

0.78

Average Sales Estimate Current Quarter

5010

Average Sales Estimate Next Quarter

3818

Fair Value

34.13

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

52.3

Max Drawdown 5-Year %

-79.7

Target Price

30.8

P/E

Forward P/E

15.58

PEG

P/S

1.32

P/B

2.07

P/Free Cash Flow

18.97

EPS

-0.82

Average EPS Est. Cur. Y

1.44

EPS Next Y. (Est.)

1.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.89

Relative Volume

0.94

Return on Equity vs Sector %

-25.4

Return on Equity vs Industry %

-16.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.13

EBIT Estimation

710.2

Koninklijke Philips N.V. NY Reg

Sector: Healthcare

Industry: Medical Devices

Employees: 67035

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

stock quote shares PHG – Koninklijke Philips N.V. Stock Price stock today

news today PHG – Koninklijke Philips N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch PHG – Koninklijke Philips N.V. yahoo finance google finance

stock history PHG – Koninklijke Philips N.V. invest stock market

stock prices PHG premarket after hours

ticker PHG fair value insiders trading

ASML – ASML Holding N.V.

Float Short %

0.35

Margin Of Safety %

-19

Put/Call OI Ratio

1.15

EPS Next Q Diff

-0.81

EPS Last/This Y

2.31

EPS This/Next Y

1.2

Price

1099.47

Target Price

1180.77

Analyst Recom

1.76

Performance Q

38.08

Relative Volume

0.66

Beta

1.86

Ticker: ASML

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	ASML	1038.03	1.21	0.86	162637
2025-11-11	ASML	1022.35	1.21	1.14	165624
2025-11-12	ASML	1036.79	1.20	0.80	168298
2025-11-13	ASML	1020	1.20	1.20	170123
2025-11-14	ASML	1006.47	1.19	1.32	171635
2025-11-17	ASML	1018.91	1.21	0.27	162199
2025-11-18	ASML	1002	1.10	0.90	173200
2025-11-19	ASML	1039.2	1.10	0.36	177173
2025-11-20	ASML	982.41	1.06	0.64	182718
2025-11-21	ASML	966.39	1.17	1.30	184282
2025-11-24	ASML	987.59	1.19	0.92	147693
2025-11-25	ASML	1003.26	1.19	0.71	152986
2025-11-26	ASML	1041.02	1.18	0.93	155381
2025-12-01	ASML	1089	1.12	0.66	152969
2025-12-02	ASML	1108.88	1.09	0.63	163456
2025-12-03	ASML	1141.03	1.09	0.87	169184
2025-12-04	ASML	1110.25	1.11	0.78	174804
2025-12-05	ASML	1099.38	1.15	0.81	179192
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	ASML	1038.79	10.1	544.3	24.64
2025-11-11	ASML	1022.42	10.1	135.9	24.64
2025-11-12	ASML	1036.72	10.1	257.2	24.64
2025-11-13	ASML	1020.29	10.1	-217.2	24.64
2025-11-14	ASML	1006.81	10.1	-57.8	24.65
2025-11-17	ASML	1020.30	10.1	389.8	24.65
2025-11-18	ASML	1003.75	10.1	133.3	24.65
2025-11-19	ASML	1039.33	10.1	827.9	24.65
2025-11-20	ASML	981.01	10.1	-6.8	24.65
2025-11-21	ASML	966.26	10.1	-560.8	24.65
2025-11-24	ASML	987.61	10.1	587.8	24.65
2025-11-25	ASML	1003.22	10.1	400.5	24.68
2025-11-26	ASML	1040.76	10.1	886.8	24.68
2025-12-01	ASML	1089.14	10.1	1121.5	24.71
2025-12-02	ASML	1108.78	10.1	1012.6	24.72
2025-12-03	ASML	1140.92	10.1	1150.9	24.72
2025-12-04	ASML	1110.33	10.1	-46.2	24.72
2025-12-05	ASML	1099.47	10.1	-176.5	24.72
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	ASML	0.00	-3.63	0.40
2025-11-11	ASML	0.00	-3.63	0.40
2025-11-12	ASML	0.00	-3.63	0.35
2025-11-13	ASML	0.00	-3.63	0.35
2025-11-14	ASML	0.00	-3.63	0.35
2025-11-17	ASML	0.00	-2.04	0.36
2025-11-18	ASML	0.00	-2.04	0.35
2025-11-19	ASML	0.00	-2.04	0.35
2025-11-20	ASML	0.00	-2.04	0.35
2025-11-21	ASML	0.00	-2.04	0.35
2025-11-24	ASML	0.00	1.60	0.35
2025-11-25	ASML	0.00	1.60	0.35
2025-11-26	ASML	0.00	1.60	0.35
2025-12-01	ASML	0.00	4.94	0.35
2025-12-02	ASML	0.00	4.94	0.35
2025-12-03	ASML	0.00	4.94	0.35
2025-12-04	ASML	0.00	4.94	0.35
2025-12-05	ASML	0.00	4.94	0.35
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

6.41

Avg. EPS Est. Current Quarter

7.53

Avg. EPS Est. Next Quarter

5.6

Insider Transactions

Institutional Transactions

4.94

Beta

1.86

Average Sales Estimate Current Quarter

9509

Average Sales Estimate Next Quarter

7909

Fair Value

895.01

Quality Score

Growth Score

Sentiment Score

100

Actual DrawDown %

3.7

Max Drawdown 5-Year %

-56.9

Target Price

1180.77

P/E

41.17

Forward P/E

36.11

PEG

1.79

P/S

11.99

P/B

19.1

P/Free Cash Flow

43.69

EPS

26.71

Average EPS Est. Cur. Y

24.72

EPS Next Y. (Est.)

25.92

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.36

Relative Volume

0.66

Return on Equity vs Sector %

-3.1

Return on Equity vs Industry %

4.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.08

EBIT Estimation

-176.5

ASML Holding N.V. - New York Re

Sector: Technology

Industry: Semiconductor Equipment & Materials

Employees: 43461

ASML Holding N.V. provides lithography solutions for the development, production, marketing, sales, upgrading, and servicing of advanced semiconductor equipment systems. It offers lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography systems solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical metrology systems to assess the quality of patterns on the wafers; and HMI electron beam solutions to identify and analyze individual chip defects. Further, the company provides computational lithography solutions, and lithography systems and control software solutions; and refurbishes and upgrades lithography systems, as well as offers customer support and related services. Additionally, it offers hardware, software, and services to chipmakers to produce the patterns of integrated circuits. The company operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

stock quote shares ASML – ASML Holding N.V. Stock Price stock today

news today ASML – ASML Holding N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch ASML – ASML Holding N.V. yahoo finance google finance

stock history ASML – ASML Holding N.V. invest stock market

stock prices ASML premarket after hours

ticker ASML fair value insiders trading

No more stocks to show

MRUS – Merus N.V

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MRUS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

QGEN – Qiagen N.V.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: QGEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y